Public Release: 

12th Annual Symposium of the Penn Center of Excellence in Environmental Toxicology

Experts to discuss latest research on exposure to environmental toxicants and how they affect development in the womb and disease in later life

University of Pennsylvania School of Medicine

PHILADELPHIA - Several critical periods over a human life span - including before birth -- determine when individuals are the most susceptible to environmental toxicants. Researchers will gather at the Perelman School of Medicine at the University of Pennsylvania this Monday to discuss these "Windows of Susceptibility" during the 12th Annual Center of Excellence in Environmental Toxicology (CEET) Symposium. CEET is an Environmental Health Science Core Center funded by National Institute for Environmental Health Sciences (NIEHS).

For the first time, there will also be a Town Hall Meeting following the symposium to discuss environmental health concerns and disparities in the Chester community, such as high rates of pre-term birth, asthma, and cancer.

WHERE: Symposium at the Smilow Commons and Auditorium
Perelman School of Medicine (PSOM)
3400 Civic Center Blvd, Philadelphia, PA 19104
Post-Symposium Town Hall at Faith Temple Holy Church
1007 West 7th Street, Chester, PA, 19013




Keynote speaker: John McLahlan, PhD, chair of Environmental Studies and professor of Pharmacology at Tulane University

Townhall Meeting Featured Guest: Linda Birnbaum, PhD, DABT, ATS Director of the National Institute of Environmental Health Sciences and the National Toxicology Program

Additional speakers from the University of Pennsylvania and other institutions

Symposium, Monday, June 19, 2017, starting at 7:30 a.m.

Post-Symposium Town Hall, 7:00 p.m.

Full schedule

In Utero Exposures

"Developmental Origins of Adult Disease" - Rebecca Simmons, MD, professor of Pediatrics, CEET Deputy Director

"In Utero Mouse Model of BPA Exposure: Physiology, Behavior and Epigenetics" - Marisa Bartolomei, PhD, professor of Cell and Developmental Biology (University of Pennsylvania) "Human In Utero Exposures to Endocrine Disrupting Chemicals" - Sara Pinney, MD, MS, assistant professor of Pediatrics (Children's Hospital of Philadelphia)

Point/Counter Point - Endocrine Disrupting Chemicals

"Toxicology Findings on BPA" - Luisa Camacho, PhD, Senior Staff Fellow (Food and Drug Administration, National Center for Toxicological Research)

"Environmental Epigenetics: A Mechanistic Link to Health, Disease, and Intervention" - Shuk-Mei Ho, PhD, Jacob G. Schmidlapp Professor and Chair of Environmental Health, Director of the Cincinnati Cancer Consortium, Director of Center for Environmental Genetics

"Perinatal exposure of rats to low doses of Zeranol induces transgeneration effects on sexual development, fecundity and susceptibility to mammary carcinogenesis" - Helmut Zarbl, professor of Toxicology, Center for Environmental Exposures and Disease Director (Rutgers)

"Environmental Hormones and Other Signals" - John McLahlan, PhD, Celia Scott Weatherhead and Albert J. Weatherhead III Distinguished Chair of Environmental Studies, professor of Pharmacology (Tulane University)

Exposure Science

"Children's Health Exposure Analysis Resource" - Lisa A. Peterson, PhD, professor of Environmental Health Sciences (University of Minnesota)

"Environmental Exposures and Neurodevelopment-Autism Spectrum Disorders" - Nathaniel Snyder, PhD, MPH, assistant professor (Drexel Autism Institute, Drexel University)

"Challenges in Measuring Endogenous and Exogenous Hormones" - Clementina Mesaros, PhD, research assistant professor and Technical Director of Translational Biomarker Core of CEET

Town Hall meeting at Faith Temple Holy Church
1007 West 7th Street, Chester, PA, 19013
Marilyn Howarth, MD, FACOEM, Center of Excellence in Environmental Toxicology (University of Pennsylvania)
Rev. Horace Strand, Pastor of Faith Temple Holy Church and Chairman of Chester Environmental Partnership (CEP)
John and Dolores Shelton, CEP members and residents of Chester
Linda Birnbaum, PhD, DABT, ATS, NIEHS and NTP director


Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $6.7 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2016 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2016, Penn Medicine provided $393 million to benefit our community.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.